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Abstract:  Recent international summits of the International Federation of Societies of Toxicologic Pathologists (IFSTP)
have debated the desirability and potential means by which the proficiency of an individual toxicologic pathologist might
be recognized and communicated throughout the world.  The present document describes the advantages and
disadvantages of implementing such a global recognition system by any means, and provides a proposal whereby
recognition might be accorded via rigorous credential review of a practitioner’s education and experience.    (J Toxicol
Pathol 2009; 22: 143–152)
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Introduction
Toxicologic pathologists are involved in the evaluation
of new products including chemicals, food components,
agrochemicals, pharmaceuticals, and medical devices.  Of
particular importance in this process are broadly trained and
experienced toxicologic “bench” pathologists responsible
for the macroscopic and microscopic evaluation and
interpretation of regulatory-type safety studies.  Decisions
by these pathologists may have a profound impact on human
health.  Their timely judgments may either permit valuable
prospective compounds to progress through development or
prevent possibly harmful substances from reaching the
market.  Consequences of inaccurate judgments may be
magnified now that many products are marketed globally.
The potential for a significant misjudgment to cause harm
worldwide will be minimized if all practicing toxicologic
pathologists involved in the evaluation of these regulatory
safety studies are well-documented to have acquired a
standard set of critical skills, knowledge, and experience.
However, the truth of this premise is not immediately clear
to lay individuals given the divergence in education and
work experience among these pathologists in different
nations.
Accordingly, a recent international summit of elected
representatives from several societies of toxicologic
pathology discussed the means by which the proficiency of
an individual toxicologic pathologist1 might be recognized
and made known to employers, regulatory agencies, and
health authorities throughout the world.  The consensus
reached during this session was communicated to the
members of the participating societies in the form of a white
paper (Ettlin et al., 2007 / 2008), which was published
concurrently in the scientific annals of the ESTP
(Experimental and Toxicologic Pathology), the JSTP
(Journal of Toxicologic Pathology), and the BSTP and STP
(Toxicology Pathology).
The contents of this prior publication outlined several
elements that should be considered when evaluating the
proficiency of a toxicologic pathologist.  The present
document extends the previous article by discussing the
following proposition: “Assuming that the toxicologic
pathology profession worldwide would benefit from a global
system for recognizing the proficiency of individual
pathologists, how might the global toxicologic pathology
community proceed to implement such a process?” A global
system for recognizing competence would need to be
structured in such a manner that it would add substantial
value for individual practitioners, and would also inspire
confidence in their competence by employers, health
authorities, regulatory agencies, and the general public.
Several essential questions must be contemplated when
considering the value (or lack thereof) in such a global
recognition system.  These can be summarized in seven
broad queries: 
  1.  What are the global standards for recognizing a
qualified toxicologic pathologist?
  2.  To what extent would a global recognition pathway
substantially augment existing means of recognizing
individual proficiency? 
 3.  What kinds of recognition are currently available, and
by what mechanism should global recognition be
conferred? 
 4.  What  institution(s) should oversee the recognition
process?
 5.  What methodology might be most suitable to global
recognition of proficiency?
 6.  What criteria should be employed to assess whether or
not an individual has attained sufficient proficiency to
merit global recognition?
 7.  How would the institution executing global recognition
ensure consistent practice across regions and time
during the recognition process? 
This paper will seek to provide preliminary answers for
these questions.  The authors hope that these remarks will
serve as central points for ongoing discussion as the global
toxicology pathology community evaluates the potential
merits of an international recognition process for proficient
pathologists.
What Are the Global Standards for Recognizing 
a Qualified Toxicologic Pathologist? 
This question is simple to ask, but perhaps will be
complex to define.  What skills will receive global
acceptance as prerequisites for proficiency? The logical
criteria for making such value judgments include an
individual’s education, work experience, and in some venues
the successful completion of a relevant examination (Ettlin
et al., 2007/2008).  However, at this time no formal
international standard exists for assessing the proficiency of
toxicologic pathologists.
The absence of a global benchmark for assessing
proficiency reflects the breadth of duties undertaken by
toxicologic pathologists.  In some situations a qualified
toxicologic pathologist will be the individual who can most
accurately detect toxicant-induced changes in tissues orGlobal Recognition of Qualified Toxicologic Pathologists 145
other specimens from regulatory-type studies.  In other
settings the designation of “qualified” might only be
accorded to a toxicologic pathologist who is sufficiently well
versed in lesion identification and many related disciplines
(pathophysiology, comparative medicine,
pharmacodynamics and pharmacokinetics, metabolism,
molecular biology, etc.) to be able to provide an integrated
understanding of a lesion’s significance and a useful context
for designing strategies to characterize and mitigate any
problems they might represent.  Therefore, the broadest
statement of this question might be, “What is an acceptable
balance between the theoretical and hands-on skills required
in a competent toxicologic pathologist?” The answer to this
query will likely dictate the best means of providing global
recognition of proficiency going forward - credential review,
examination, expanded peer review, or maintaining the
status quo (based on existing national and regional
credentialing processes as well as peer review).  The
international community of toxicologic pathologists must
first determine the essential core skills of a qualified
practitioner on a global level before a meaningful discussion
of mechanisms for demonstrating proficiency can be
undertaken.  The current patchwork of national and regional
certifying systems (whether by credential review or
examination) supplemented by rigorous peer review and
international outreach efforts to establish common
educational and practice methods in toxicologic pathology
should provide a reliable means of ensuring adequate
proficiency of toxicologic pathologists throughout the globe.
Addition of a global recognition mechanism to these existing
criteria would provide a single, globally applicable
document demonstrating an acceptable degree of
proficiency.
To What Extent Would a Global Recognition 
Pathway Substantially Augment Existing Means 
of Recognizing Individual Proficiency?
Traditionally the decision regarding the basic
proficiency of toxicologic pathologists has been a function
of the employer’s needs and the individual’s performance,
and not subject to oversight by national or regional health
authorities or regulatory agencies.  The current consensus
among most clients for toxicologic pathology services (e.g.,
firms that develop medicinal or chemical products and/or
medical devices, contract research organizations, health
authorities, and regulatory agencies) is that present practices
for recognizing the proficiency of individual practitioners,
when coupled with the regular use of peer review by other
experienced toxicologic pathologists, are capable of
ensuring the proper acquisition and quality interpretation of
toxicologic pathology data.  However, regulatory guidelines
requiring that pathology data be acquired and interpreted by
a “qualified” pathologist (EMEA, 2002; FDA, 2004) have,
by not defining the attributes of a “qualified” individual,
created ambiguity regarding if and how proficiency should
be evaluated and documented.  This requirement, coupled
with the existence of experienced practitioners in the field
who lack any formal certification as pathologists, suggests
that a worldwide benchmark for recognizing proficiency as a
competent toxicologic pathologist would be beneficial.
Toxicologic pathologists utilize their unique training,
experience and credentials to obtain employment in the field,
even if they move abroad to practice.  Regulatory agencies
seldom dispute the ability of a toxicologic pathologist based
on paper qualifications.  Nevertheless, a formal, global
system for recognizing proficiency in toxicologic pathology
would offer many advantages to multiple constituencies,
including toxicologic pathologists (both individually and
collectively), their employers, and the entities that rely on
their expertise (e.g., health authorities, regulatory agencies,
academic institutions, and the general public).  Prominent
examples include:
* Ready international recognition of qualified
individuals,
*  Clear and consistent published criteria for recognizing
“proficient” practitioners,
*  A well-defined system for recognizing those who do
not currently have ready access to regional or national
postgraduate certification schemes,
* Improved global harmonization on standards for
training future generations of toxicologic pathologists,
and
*  Enhanced international employment opportunities.
In short, an effective international system for
recognizing proficiency in toxicologic pathology could serve
to both ease and speed the ongoing process of global
integration that is a prominent practice of multi-national
corporations in the 21st century.
What Kinds of Recognition Are Currently 
Available, and by What Mechanism Should 
Global Recognition Be Conferred?
This ostensibly straightforward topic is subject to
considerable debate due to the divergence in existing
national and regional practices for evaluating the proficiency
of toxicologic pathologists.  An international standard for
recognizing the proficiency of toxicologic pathologists could
take many forms.  Logical choices would include
documenting the successful completion of a core curriculum
covering universally accepted knowledge in the field,
increased use of pathology peer review (without respect to
national borders), and/or a formal accrediting system based
on either a formal examination or credential review.  Some
locales administer a formal certifying examination targeted
specifically to the toxicologic pathology discipline (e.g.,
JSTP).  Such tests directly assess whether or not a given
individual has an essential core body of knowledge in the
field.  An alternative examination format in Germany
provides a veterinary pathologist already certified as a
diagnostician (FTA Pathol, granted by oral examination after
a 5-year training program) an additional certificate in
toxicologic pathology after 2 more years of training under an146 Global Recognition of Qualified Toxicologic Pathologists
experienced toxicologic pathologist and another oral
examination.  In contrast, toxicologic pathologists in the
Netherlands and Switzerland are registered by the CRP/TP
and the “Schweizerische Vereinigung fuer Tierpathologie”
(SVT) by reviewing their toxicologic pathology credentials
following the successful completion of a 4-year, on-the-job,
individualized training program under the supervision of a
previously recognized senior toxicologic pathologist;
registrants are then reappraised at 5-year intervals to confirm
that suitable continuing education and experience within the
field have been maintained.  Still other locales oversee
thorough certifying examinations in general and veterinary
anatomic and/or veterinary clinical pathology (e.g., ACVP,
DESV [anatomic pathology], ECVP, ECVCP, and JCVP).
Such examinations are designed to verify that sufficient
theoretical and practical knowledge in veterinary diagnostic
pathology has been gained in the course of a pathology
training program to effectively perform pathology
investigations.  They are not intended to confirm that an
individual has gained an understanding of the core
knowledge specific to the toxicologic pathology field,
though there might have been exposure to toxicologic
pathology.  Nevertheless, individuals who have completed
such rigorous pathology examinations are usually regarded
as able to apply their basic pathology skills to toxicologic
pathology problems.  All of these mechanisms have been
considered fitting methods for assessing toxicologic
pathologists, including those working in research, based on
their successful use over years (e.g., ECVP) to decades (e.g.,
ACVP, CRP/TP, DESV, FRCPath, FTA Pathol, FHV
Pathol, JCVP, and JSTP).  The existence of comparable
training opportunities in the past which have since
disappeared must be taken into consideration when
evaluating the educational qualifications of some older
toxicologic pathologists (e.g., CES, DU).
The existing methods by which proficiency in
toxicologic pathology is assessed in different parts of the
world suggest that several potential points of contention
might arise when considering a new global mechanism for
recognizing competency in this discipline.
*  First, those scientists who have previously achieved
recognition as proficient toxicologic pathologists using
one of the means noted above will understandably be
reluctant to undertake the effort needed to attain another
credential.  A feasible solution to this dilemma would
be to recognize existing certifications, if they fulfill the
criteria of the new global system.
*  Second, the implementation of a new global system for
recognizing proficiency in toxicologic pathology might
be perceived to devalue some of the existing national
and regional pathways if, in the future, health
authorities or regulatory agencies begin to only accept
those data generated by practitioners holding a global
credential.  The authors believe this scenario to be
unlikely, on the assumption that the existing national/
regional schemes will provide an assessment of
comparable rigor when compared to the international
mechanism.
*  The final point of conflict is likely to be agreement on a
mechanism for conferring global recognition (see also
section below “What methodology might be most
suitable to global recognition of proficiency?”).
Institutions that advocate certifying examinations
contend that such tests provide a more rigorous,
objective, and consistent appraisal of proficiency than
would a simple review of documents detailing one’s
education and experience.  However, others assert that
a suitable progression of educational opportunities and
practical experience with direct bearing on the daily
practice of toxicologic pathology has greater relevance
than the successful conclusion of an exacting
examination.
We anticipate that significant dialogue will be required
within the international toxicologic pathology community
before these conflicts can be resolved, even for such a
seemingly worthy goal as creating a global recognition
process to confirm that practitioners have the minimal
educational requirements and experience needed to truly
guard the public health.
What Institution(s) Should Oversee a Global 
Recognition Process?
The logical consequence of premise no. 3 above is that
any global scheme for recognizing proficiency in toxicologic
pathology should be administered by an entity with global
reach rather than by a more localized body (e.g., such
regional societies as the BSTP, ESTP, JSTP, or STP).  Of
course, these societies, and possibly other societies such as
(veterinary) pathology societies at large, must be involved.
An existing global organization that might assume this
role is the International Federation of Societies of Toxicologic
Pathologists (IFSTP).  This entity was founded by the
respective national member societies in 1989 to - among other
activities - promote the adoption of global standards for
recognizing the capabilities of “qualified” toxicologic
pathologists (IFSTP website); most STPs across the globe
either belong to2 or are seeking to join3 the IFSTP.  One
possible method by which the IFSTP could oversee this might
be through the International Academy of Toxicologic
Pathology (IATP), an IFSTP derivative organized in 1999 to
recognize experts (designated IATP “Fellows”) in toxicologic
pathology.  The latter experts can either be broad based or be
specialists in a dedicated field of toxicologic pathology i.e.
this recognition is not necessarily overlapping with the skills
required for the toxicologic pathologists/practitioners of
regulatory-type nonclinical studies as discussed in this paper
(see Note 1).  Fellows of IATP are selected based on a point-
driven review of documented professional credentials that
emphasizes both longstanding educational accomplishments
(theory) and experience (practice).
The main advantage of tasking the IATP with
administering such a global recognition system is that the
mandated worldwide focus of IATP would facilitateGlobal Recognition of Qualified Toxicologic Pathologists 147
standardizing the review process throughout the world.  A
mechanism would need to be fashioned by which the
collective will of the member societies would have a means
for overseeing the process; a likely means would be to place
this responsibility with the IFSTP.  A disadvantage of using
the IATP for this purpose is the need to achieve consensus
regarding an entirely new set of criteria against which
proficiency in pathology might be measured; this
requirement arises from the bias of the current Fellow
criteria toward intellectual achievements (e.g., publication
record, external presentations, etc.) rather than proven
excellence at performing those laboratory (“bench”)
functions usually fulfilled by study toxicologic pathologists.
Another potential disadvantage of using IATP in this role is
that the sudden influx of applicants seeking global
recognition could overwhelm the small size of the IATP
credentialing committee.  This objection could be met by
expanding the existing IATP committee with IFSTP-
appointed representatives, or better yet by forming a new
IATP committee to specifically address this new mandate.
An alternative approach might be for the IFSTP to
moderate negotiations among its member societies to
establish a minimum standard for proficiency in toxicologic
pathology, after which the member societies would fashion
means for their own constituents to meet that standard (either
with or without IFSTP oversight).  We predict that this latter
option will prove untenable given the desire of individual
societies of toxicologic pathology to maintain their
traditional independence, which would likely preclude the
adoption of a standard recognition system across all
organizations.
A third option might be for the IFSTP and/or the IATP
to assume a new responsibility as the oversight body tasked
with sanctioning the certifying programs administered by the
national and regional societies.  This alternative is feasible in
principle as the IFSTP has been engaged in efforts to
recognize qualified toxicologic pathologists since its
inception (e.g., IFSTP, 2003).  Such an initiative would be
particularly important, for future programs that will arise in
developing countries which currently lack a long tradition of
toxicologic pathology within their borders.  Once again,
however, we predict that this alternative will be untenable,
for three key reasons.  First, such an authority does not
currently fall within the mandate of the IFSTP (a
confederation of societies of toxicological pathology to build
new societies, support the member organizations by
integration and coordination of international activities and
initiatives, and to set standards in toxicological pathology) or
the IATP (a small group which recognizes individual
expertise and also promotes education).  Second,
implementing this practice would require more resources
than could be marshaled given the existing administrative
machineries of the IATP and the IFSTP.  Finally, in many
venues the certifying procedures for those engaged in
toxicologic pathology are not governed by the national or
regional STP but rather by another body, which might
understandably resent any effort to impose an external
control on its activities.  The IFSTP and/or IATP might
reasonably be expected to provide both information and
experienced mentors to aid new national societies in
developing rigorous credentialing programs.
The discussion among representatives of the member
societies present at the Fall 2008 IFSTP Executive
Committee meeting (September 24, in Edinburgh, Scotland)
revealed a consensus favoring joint IFSTP / IATP
participation in any future global recognition system for
toxicologic pathologists whose primary focus is macro- and
microscopic pathology of regulatory-type nonclinical safety
studies.  The delegates felt that the IFSTP should take the
lead in coordinating debate among the member societies
regarding the proper design of a global recognition process
(albeit with input from IATP), while the IATP would be
expected to direct assessment of the applications (possibly
with assistance from IFSTP representatives).  This
arrangement would take maximal advantage of the existing
international institutions and recognition machinery, thereby
expediting the evolution of a global system for recognizing
the proficiency of toxicologic anatomic pathologists whose
principal role is microscopic evaluation of tissues4.  This
structure is also logical in that an IATP / IFSTP qualification
as a capable pathologist could also lead, with a higher
number of scientific publications and more academic
training activities, to recognition as “Fellow” (the
designation now given by the IATP).  Thus, all means of
global recognition as a proficient toxicologic pathologist
could be efficiently administered by a single entity.  Further
discussion will be required to indicate whether or not the
IATP and the member societies of the IFSTP concur with the
position of the IFSTP Executive Committee in this regard.
What Methodology Might Be Most Suitable to 
Global Recognition of Proficiency?
The main issue that must be contemplated when
considering a new international mechanism for identifying
proficiency in pathology is the nature of the process by
which recognition is to be affirmed.  The two basic models to
achieve this purpose are administration of a certifying
examination or a review of documented credentials.  Given
the existing divergence in credentialing mechanisms among
various national and regional societies of toxicologic
pathology, the easiest avenue for developing an international
recognition system in this field in the near future will most
likely be recognition by credential review.  However, a
recognition model that simply reviews a person’s self-
reported record of training and experience without formally
testing his or her abilities would likely be more subject to
flawed decisions regarding proficiency than a system that
employs a globally accepted examination covering a
universally accepted body of theoretical and practical
knowledge.  A rigorous international examination process,
supported by all the societies of toxicologic pathology and
overseen by recognized toxicologic pathologists from
around the world, would provide the strongest as well as the148 Global Recognition of Qualified Toxicologic Pathologists
most credible and legally defensible measure of proficiency
in toxicologic pathology.  Creation and administration of
such an instrument would require significant resources
including clear international agreement on what constitutes
competency and the core body of necessary knowledge;
liaison with academic bodies in different countries; many
hours of professional effort by toxicologic pathologists and
professional educational consultants to create and validate
test questions and ways to determine fair and defensible
passing scores; and considerable financial support.  Other
obstacles to a universal examination process are language
barriers (as testing in a non-native language is difficult at
best) and region-specific customs.  Nevertheless, with
concerted effort and consistent financial support, such an
examination could conceivably be developed in 5 to 10
years.
Should such a global recognition mechanism be
considered desirable by the international toxicologic
pathology community, we propose that the system be
fashioned with two tiers: an initial, temporary process based
on credential review (i.e., does one’s record of education and
experience predict the likelihood of proficiency) followed
some years later by an examination-based process.  The
greatest danger of this gradual approach is that inertia might
prevent the profession from ever proceeding to the second
tier.  This threat may be met by affirming up front that the
1st-tier (credential review) mechanism will only be available
for a finite period - ideally within five to seven years after a
global recognition process is implemented.  An
uncomplicated means of expediting the transition would be
to establish the exam-based global recognition process as a
modular training program (similar to the existing BSTP
system), each session of which would be followed by a test
(as is done currently to qualify European Registered
Toxicologists).  The cycle of modules could be offered on
each continent over a period of three to five years so that
apprentice pathologists could train with relative convenience
and little expense.  Using this approach, all persons would
have the same educational base (thereby affording a truly
global exposure to fundamental theories and practices in the
field) and undergo a comparable trial by examination (thus
providing an objective means for removing cultural bias
from the recognition process).
What Criteria Would Be Appropriate for Global 
Recognition of Proficiency?
The best benchmark for validating an individual’s
ability as a qualified toxicologic pathologist is repeated
success in the crucible of pathology peer review.  This
mechanism is already utilized throughout the world, and it
likely will - and should - remain the gold standard for
affirming competence for years to come.  Unfortunately,
peer review within the context of proprietary studies is often
not available for third-party review as a means of
documenting competence.  Furthermore, peer review per se
does not automatically demonstrate proficiency, as
deficiencies which might be corrected during peer review
might arise from incompetence or partial competence -
including those arising because the competence of the peer
reviewer cannot always be taken for granted.  However,
certain qualities are held in common by proficient
toxicologic pathologists, and such knowledge and skills
might be readily adapted to serve as criteria for an
international recognition system.  As outlined in the prior
paper (Ettlin et al., 2007 / 2008), successful practitioners will
have acquired foundational knowledge in toxicologic
pathology via some combination of education and on-the-job
experience.  The most effective educational pathway will
include formal professional training in human or veterinary
medicine followed by subsequent post-graduate training in
pathology (often emphasizing comparative or laboratory
animal pathology) and some appropriate allied discipline
(generally toxicology or pharmacology).  Extensive practical
experience must be obtained within the academic setting
and/or through an extended practicum - an apprenticeship, if
you will - in applied toxicologic pathology under the tutelage
of an experienced mentor.  Not all components of this
pathway are, however, absolute requirements.  An individual
who has successfully completed most or all facets of such a
program should have the skills to function proficiently as an
entry-level toxicologic pathologist anywhere in the world.
Any mechanism for recognizing the proficiency of a
toxicologic pathologist must be tailored to a specific sub-
discipline (e.g., anatomic or clinical or discovery or
regulatory pathology) within the field of toxicologic
pathology.  With this in mind, the criteria and point system
outlined in Table 1 have been formulated as a potential basis
for evaluating whether or not a person would have the core
knowledge and skills sufficient to render him or her qualified
as a toxicologic pathologist for regulatory-type nonclinical
studies in the opinion of those who must utilize his or her
interpretations.  In fact, the real target population of these
criteria is the “bench” pathologist with at least a few years of
relevant on-the-job experience - those individuals whose
roles include macroscopic and microscopic evaluations of
tissue morphology and integrated interpretation and
communication of pathology data of regulatory-type
preclinical safety studies.
The proposed list of credentialing criteria is not
intended to recognize those scientists whose chief
responsibilities are to conduct experiments (discovery
pathologists), evaluate non-anatomic data (clinical
pathologists), or manage other investigators.  Should a
recognition system for study pathologists be forthcoming,
new criteria could be developed in the future to recognize the
proficiency of these other disciplines in toxicologic
pathology.
How Would the Institution Executing Global 
Recognition Ensure Consistent Practice Across 
Regions and Time?
The entity tasked with administering an internationalGlobal Recognition of Qualified Toxicologic Pathologists 149
system to recognize proficiency in toxicologic pathology
must necessarily maintain unswerving standards.  Given that
such a mechanism must rest firmly on a globally acceptable
set of pre-defined criteria, the obvious means of best
guaranteeing consistent application would be to entrust
recognition decisions to a single review body comprised of
proficient toxicologic pathologists from throughout the
world.  The advantage to this approach would be that all
individuals seeking recognition would be evaluated by a
single board, thereby providing all applicants with a
common venue for making their case.  Two possible
disadvantages include a potentially heavy workload placed
on such a small reviewing group and the difficulty in judging
candidates who practice in different cultural and regulatory
settings.  The authors believe that the first objection would
be temporary, as any initial large number of applications
would quickly clear the backlog of potential candidates and
thereby lead to a much lower burden thereafter.  The second
disadvantage could be addressed readily in at least three
ways: requiring all candidates to submit their applications in
a common language and format, making global review board
members from a given region responsible for first assessing
the proficiency of candidates from their region, or having the
global review board evaluate a certain percentage (10% to
25%) of all applications which have been forwarded by
national and/or regional committees.  The authors predict
that either of the last two options would be more suitable
means of approaching this potential disadvantage.
A corollary of any recognition process is that a
proportion of existing practitioners will not meet the
accepted standards for proficiency (i.e., are deemed
“unqualified”).  An obvious question arises with respect to
their destiny.  Will such individuals be suspended, or even
become unemployable? We predict that such dire fates will
not await these individuals, as almost all of them will be
recently graduated “apprentices” gaining their initial on-the-
job training in toxicologic pathology; these pathologists
should in time gain the carefully supervised experience
required to receive global recognition as “qualified.” We
anticipate that cases will be quite rare - if they ever arise at
all - where a long-practicing toxicologic pathologist will be
deemed unqualified and then refused global recognition if
they have had regular participation in the already existing
practice of regular peer review.  Ideally, if a global system
for recognizing quality is deemed desirable, we recommend
that the credential review scheme be retired as soon as
possible in favor of an examination format as such platforms
are inherently more legally defensible in the face of a
challenge from a disappointed candidate.
Potential Arguments Against a Formal Global 
System for Recognizing Proficiency
The authors wish to emphasize that the intent of this
article is not to introduce an authoritative, unalterable,
credentialing mechanism.  Instead, the purpose is to
stimulate energetic debate regarding the appropriateness of
the given characteristics and point assignments (Table 1) vis-
à-vis the desired goal of recognizing that a toxicologic
pathologist is proficient in critical basic areas of
competence, and the desirability of implementing a
worldwide recognition system.  The authors recognize the
difficulties and pitfalls that this proposal may face and
propose to address them in the following paragraphs.
At least four arguments against establishing an
international recognition system based on credential review
have been raised.
A. “Defensible  certifications require formal testing.”
Some believe that any formal global recognition system
should be based on an examination that tests both
theoretical and applied knowledge rather than on mere
credential review.  A rigorous global examination
process for competency in toxicologic pathology would
be more consistent, fair, and reproducible (with some
limitations) across countries, and therefore more
defensible than any system based on qualitative or
semi-quantitative evaluation of one’s education and
experience.  These potential advantages must be
weighed against the extent of the added benefit as well
as cost, effort, and time required to implement an
effective global examination process.
B.  “Suitable certifying tests already exist.” Certain locales
have long had or have recently instituted comparable
examinations in general pathology (medical or
veterinary, e.g., ACVP, ECVP, ECVCP [clinical
pathology], FTA Pathol, JCVP, DESV [anatomic
pathology]), or toxicologic pathology (e.g., FRCPath,
JSTP).  Presumably, the vast majority of experienced
toxicologic pathologists would be likely to have
attained accreditation from some other venue, and
therefore will not require an additional form of
recognition.  A possible counterargument is that some
examinations of this nature, especially those
emphasizing local academic prejudices and/or focused
broadly on general pathology, will not have sufficient
breadth to serve as a global attestation of quality in the
specific field of toxicologic pathology.
C.  “Credential-based recognition is too lenient.” New
societies of toxicologic pathology which will be
forming in developing countries should be strongly
encouraged - with suitable assistance from experienced
colleagues in STPs from developed nations - to create
curricula, apprenticeships, and certifying examinations
appropriate to both the local needs and the current best
worldwide practices.  The primary concern is that new
societies lacking sufficient resources to create and
maintain a credible examination may choose to
establish a relatively lax national or regional system
based on credential review or pro forma testing to
provide cachet to their own professionals; the
recognition of marginally qualified individuals could
erode the credibility of credential review, thereby
defeating the point of a global recognition mechanism.
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review of curricula for pathologists by professional
institutions (e.g., private industry, regulatory bodies) is
adequate, so the proposed registry does not bring value
to the standard of work that is undertaken while adding
a level of bureaucracy.
These concerns lead to the conclusion that any form of
credentialing review should heavily over-weight an
educational pathway in which a systematic medical or
veterinary medical education is followed by extensive
pathology practice (experience in either an established
residency program or a formal on-the-job apprenticeship in
pathology), the efficacy of which is then documented by
successful completion of at least one relevant examination.
Thus, global recognition as a proficient toxicologic
pathologist should be much more difficult to obtain if an
individual follows an alternative pathway in preparing for a
toxicologic pathology career.
The criteria and scale given in Table 1 have direct
relevance for the arguments given above.  Specific
counterpoints follow here.
A.  A valid counterargument to point A above is that the
assignment of points in Table 1 is weighted so that
recognition by credential review will not be a trivial
enterprise, but rather an ordeal as demanding as any of
Table 1. Proposed Criteria and Scale for Point Assignment
Minimum total points required for recognition=20,
at least 10 of which must come from experience (see Section 2 below)
Candidates must be members of an STP belonging to the IFSTP 
and practice toxicologic pathology as a primary responsibility
Section 1 EDUCATION AND CERTIFICATION Max. Points
  Possible 
1.1 Degree(s) in relevant field a
1.1.1 Veterinary or medical degree or equivalent health professional degree,  6
or license to practice such a health profession
1.1.2 Ph.D. or equivalent diploma in pathology, toxicology or a related field,  4
or habilitation (P.D.) or professorship in these disciplines
1.1.3 M.S. or equivalent diploma in pathology, toxicology, or a related field 2
1.2 Formal recognition in pathology or toxicology
1.2.1 Successful completion of an anatomic pathology examination b 4
1.2.2 Toxicologic pathology registration b 4
1.2.3 Completion of one toxicology examination  1
OR Completion of toxicology registration 
Section 2 PRACTICAL EXPERIENCE IN TOXICOLOGIC PATHOLOGY  Max. Points
Possible
2.1 Postgraduate practicum in pathology or toxicology
2.1.1 Casework in diagnostic anatomic pathology - training and service  5
to be completed during either an accredited residency program or as a portion
of an accredited graduate program in pathology at a medical or veterinary school
(2 points/year for the first 2 years of casework, then 1 point/year)
2.1.2 Toxicologic pathology apprenticeship - documented on-the-job training in  5
academia OR government OR industry (2 points/year for the first 2 years, 
then 1 point/year) c
2.1.3 Residency in toxicology, documented program at a medical or veterinary school 2
 (1 point/year)
2.2 Experience in toxicologic pathology c
2.2.1 Practice as an anatomic pathologist for toxicology studies used to identify,  No  Limit 
investigate, register, or monitor products (2 points/year for the first 2 years, 
then 1 point/year)
a Degrees must be obtained from an accredited college or university.
b Denotes that a maximum of 4 points can be applied if both pathology credentials (1.2.1 and 1.2.2) are held.
c Denotes that this activity must be attested by a senior scientist who is generally accepted as a qualified toxicologic
pathologist (usually an individual who has served as the candidate’s supervisor and overseen at least the two most
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the existing recognition paradigms for identifying
proficiency in toxicologic pathology.  The organization
responsible for the international recognition system will
be working closely with those responsible for the
national and regional accreditation pathways.  Thus, the
proper focus for this issue is not competition, but rather
ensuring that any given recognition system will have
global credibility and acceptance. 
B.  With respect to point B above, the authors acknowledge
the effectiveness of the existing national and regional
credentialing processes used to identify proficient
toxicologic pathologists.  The potential credential
review mechanism proposed in Table 1 is not intended
to supplant the current methodology of accreditation,
but rather to provide an additional means by which
experienced pathologists might attain formal
recognition as qualified toxicologic pathologists.  A
compromise which might serve to quell contentions that
credential review should not be implemented at all now
that many regional pathology examinations are
available would be to offer credential review only for a
limited transition period (i.e., until a global certifying
examination in toxicologic pathology can be
implemented).
C.  Regarding Point C above, it is essential that criteria for
any international recognition system be applied in a
consistent way worldwide.  This condition necessarily
requires that some supervisory body be constituted to
oversee the process.  The authors predict that such an
entity will have an international membership and
conduct its business by democratic principles.
D.  Point D may be countered by recognizing that while in
a large company or regional regulatory body
experienced persons will have the knowledge and
network to appropriately assess/review the curricula
vitae of candidates, qualified evaluators will often be
lacking or be scarce in smaller institutions.  In this latter
situation, the value of a reliable international reference
body will be large.
Conclusions: What Course Should the 
International Community of Toxicologic 
Pathologists Pursue Now?
The unrelenting pace at which globalization is
progressing in general is already impacting the practice of
toxicologic pathology.  The authors believe that the global
toxicologic pathology community will benefit if it begins
now to develop common practices by which a proficient
toxicologic pathologist working at the bench reviewing
tissues to identify and interpret compound-induced lesions in
the context of regulatory-type nonclinical studies can be
rapidly and reliably identified by his or her peers - and by
institutions which depend on the high quality of his or her
product.
With this goal in mind, the IFSTP recommends that the
international toxicologic pathology community initiate a
formal dialogue to consider the desirability and, if
warranted, the means of establishing (1) global benchmarks
for required core knowledge in toxicologic pathology and (2)
a global mechanism by which proficiency as a toxicologic
pathologist (broad general anatomic pathology specialty)
might be recognized.  Successful implementation of these
twin objectives might be anticipated to bolster the credibility
of individual members from national and regional societies
of toxicologic pathology while facilitating the decision-
making process at those institutions (e.g., industry,
regulatory bodies, and health agencies) that depend on the
high quality of scientific interpretations rendered by these
professionals.  The first purpose is being undertaken
successfully in a gradual fashion by the continuing labors of
experienced toxicologic pathologists to instruct and execute
peer reviews without regard to national borders.  Incremental
progress toward the second goal might be achieved in the
near future if due consideration of the potential recognition
mechanism given in Table 1 leads to global acceptance of a
workable international recognition system.  Time is on our
side as the existing web of national and regional certifying
procedures coupled with regular peer review affords a
consistent way of guaranteeing the quality of toxicologic
pathology data sets across the globe.  Nevertheless, a time
appears to be coming when a readier means of recognizing
the proficient practitioner in the field might be welcome,
especially as toxicologic pathology centers which will grow
in developing nations become common spots for outsourcing
work in this field.
Please share in this debate by sending your comments,
concerns, questions, and suggestions to the duly elected
representatives of your local society of toxicologic
pathology or to the editor of a toxicologic pathology journal
so that your thoughts may inform the discussion.  The
question at hand concerns the future course of our
profession.  All of us must work together to find the best way
forward for ourselves and our professional descendents.
Notes
1  In this paper the terms ‘toxicologic pathologist’ and
‘practitioner’ - if not otherwise specified - are used for
broadly trained and experienced pathologists involved
in macroscopic and microscopic tissue evaluation,
correlation of tissue findings with clinical pathology
data, and interpretation of regulatory-type nonclinical
safety studies, often under Good Laboratory Practice
(GLP) rules, and generally designed according to
internationally accepted standards.  The output of these
pathologists are reports generally of standard regulatory
studies submitted to regulatory agencies around the
world for marketing approval of drugs, chemicals, food
components, etc.  The task of these pathologists is
distinctly different from that of research or academic
pathologists interested in toxicities of particular organs
or organ systems (their main output are often scientific
publications); from clinical pathologists specializing in152 Global Recognition of Qualified Toxicologic Pathologists
analysis and interpretation of clinical chemistry,
hematology, urinalysis, and the like; from pathologists
engaged in other methods, such as toxicogenomics, etc.
2 Current IFSTP membership includes the regional
societies of toxicologic pathology representing Europe
(ESTP) and North America (STP) as well as the
national societies of toxicologic pathology from France
(SFPT), India (STP-I), Italy (SIPTS), Japan (JSTP), the
Netherlands (NVT), South Korea (KSTP), and the
United Kingdom (BSTP). 
3 A dedicated society recently founded in Latin America
is just beginning the process of applying for IFSTP
membership.
4 The reason for limiting the initial global recognition
process for “bench” pathologists to those individuals
performing macro- and microscopic evaluation of
nonclinical safety studies rather than those analyzing
clinical pathology data is that the first specialty is
heavily used in toxicologic research settings throughout
the world, while the second one (clinical pathology) is
currently limited as a separate specialty to some nations
/ regions (Ettlin et al., 2007 / 2008).
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